Celldex Therapeutics Announces Upcoming Presentation at the Cowen and Company 35th Annual Health Care Conference
A live webcast of the presentation will be available online on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay of the presentation will be available through
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response. Visit www.celldex.com.
CONTACT: Celldex Company Contacts: Investors:
Sarah CavanaughVice President of Investor Relations & Corp Communications Celldex Therapeutics, Inc.(781) 433-3161 firstname.lastname@example.org or Media: Dan Budwick Pure Communications, Inc.(973) 271-6085 email@example.com
News Provided by Acquire Media